UroGen Pharma Appoints David Lin as New Chief Commercial Officer
Go back to UroGen Pharma Appoints David Lin as New Chief Commercial Officer| (NASDAQ: URGN) | Delayed: 38.02 +0.08 (0.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $37.94 | 52 Week High | $ | |||
| Open | $37.54 | 52 Week Low | $ | |||
| Day High | $38.58 | P/E | N/A | |||
| Day Low | $36.88 | EPS | $ | |||
| Volume | 821,801 | |||||

